Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!

Boudjelal, Mohamed; Nehdi, Atef; Islam, Imadul

Boudjelal, Mohamed; Nehdi, Atef; Islam, Imadul.

Boudjelal M; King Abdullah International Medical Research Centre, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard Health Affairs , Riyadh, Saudi Arabia.
Nehdi A; King Abdullah International Medical Research Centre, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard Health Affairs , Riyadh, Saudi Arabia.
Islam I; King Abdullah International Medical Research Centre, King Saud Bin Abdulaziz University for Health Sciences, King Abdulaziz Medical City, Ministry of National Guard Health Affairs , Riyadh, Saudi Arabia.

Expert Opin Drug Discov ; 15(11): 1233-1235, 2020 11.

Article in English | MEDLINE | ID: covidwho-599591

Subject(s)

Betacoronavirus/immunology; Coronavirus Infections/prevention & control; Drug Industry/standards; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Viral Vaccines/supply & distribution; COVID-19; COVID-19 Vaccines; Coronavirus Infections/immunology; Drug Development; Drug Discovery; Drug Industry/trends; Humans; SARS-CoV-2; Viral Vaccines/immunology; Viral Vaccines/standards

Keywords

Covid19; Drug discovery; biotechnology; pharma industry

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Drug Industry / Pandemics / Betacoronavirus Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Expert Opin Drug Discov Year: 2020 Document Type: Article Affiliation country: 17460441.2020.1777980

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google